Abstract
Berbamine is an alkaloid, separated from Berberidaceae, Menispermaceae or Ranunculaceae plants. Nowadays, it mainly comes from chemical synthesis. The current clinical formulation is berbamine hydrochloride tablets. It has wide pharmacological effects, low adverse reactions, and low long-term toxicity. It is used in the prevention and treatment of patients with cancer, which is due to radiotherapy- and chemotherapy-induced neutropenia or due to benzene poisoning, radioactive substances, and drug-induced neutropenia. However, the other effects, mechanisms and clinical applications of barbamin and its derivatives, especially the using in tumor and diabetic antaract, need further research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Greathouse G, Rigler N. Isolation of the alkaloids, berberine and berbamine, from Mahonia Swaseyi. Plant Phydiol. 1940;15(3):563–4.
Liu G, Chen B, Song W, Xiao P. The comprehensive utilization of Berberis poiretii schneid – the medicinal value of berberine and berberine’s content in 22 kinds of Berberis. Chin Bull Bot. 1978;20(3):255–7.
Ren Y, Lu L, Guo TB, Qiu J, Yang Y, Liu A, Zhang JZ. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. J Immunol. 2008;181:1491–8.
Nam S, Xie J, Perkins A, Ma Y, Yang F, Wu J, Wang Y, Xu RZ, Huang W, Horne DA, Jove R. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells. Mol Oncol. 2012;6(5):484–93.
Wang J, Feng Y, Hu Y, Zhang G, Hu R. Research progress on antitumor effect and mechanism of berbamine and its derivatives. Tianjin Med J. 2012;40(12):1273–5.
Lin C, Huang X. The clinical observation of Shengbai amine (berbamine) on the treatment of leukopenia induced by chemotherapy. Tradit Chin Med Patent Prescription. 1996;07:29.
Kapoor S. Emerging role of berbamine as an anti-cancer. Agent in systemic malignancies besides chronic myeloid leukemia. J Zhejiang Univ Sci B. 2012;13(9):761–2.
Zhao Y, Tan Y, Wu G, Liu L, Wang Y, Luo Y, Shi J, Huang H. Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloicl leukemia. Int J Hematol. 2011;94(2):156–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Song, XY., Kong, LL., Chen, NH. (2018). Berbamine. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_80
Download citation
DOI: https://doi.org/10.1007/978-981-10-8022-7_80
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8021-0
Online ISBN: 978-981-10-8022-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)